Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Torres

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
BMC Nephrology|February 26, 2021
The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trialsRobin W M Vernooij, Way Law, Sanne A E Peters, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2025
Corrigendum to" Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes," [Eur J Cancer 2025 May 15:221:115404.]Marta Fortuny, Marta García-Calonge, Óscar Arrabal, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2026
Corrigendum to "Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes" [Eur J Cancer (May) (2025) 15:221:115404]Marta Fortuny, Marta García-Calonge, Óscar Arrabal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 10, 2021
Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort StudyMónica Furlano, Victor Martínez, Marc Pybus, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2021
Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological responseMattias Mandorfer, Fanny Turon, Sabela Lens, et al.
British Journal of Cancer|December 10, 2025
ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumorsLaura Solé, Eric Canton, María Maqueda, et al.
Orphanet Journal of Rare Diseases|November 14, 2018
Applicability and added value of novel methods to improve drug development in rare diseasesMarian Mitroiu, Katrien Oude Rengerink, Caridad Pontes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trialsC Marijn Hazelbag, Sanne A E Peters, Peter J Blankestijn, et al.
Hepatology (Baltimore, Md.)|March 17, 2015
Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter studyFederica Cerini, Javier Martínez Gonzalez, Ferran Torres, et al.
European Journal of Radiology|December 31, 2020
Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practiceJordi Rimola, Leonardo G Da Fonseca, Víctor Sapena, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
BMC Nephrology|February 26, 2021
The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trialsRobin W M Vernooij, Way Law, Sanne A E Peters, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2025
Corrigendum to" Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes," [Eur J Cancer 2025 May 15:221:115404.]Marta Fortuny, Marta García-Calonge, Óscar Arrabal, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2026
Corrigendum to "Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes" [Eur J Cancer (May) (2025) 15:221:115404]Marta Fortuny, Marta García-Calonge, Óscar Arrabal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 10, 2021
Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort StudyMónica Furlano, Victor Martínez, Marc Pybus, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2021
Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological responseMattias Mandorfer, Fanny Turon, Sabela Lens, et al.
British Journal of Cancer|December 10, 2025
ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumorsLaura Solé, Eric Canton, María Maqueda, et al.
Orphanet Journal of Rare Diseases|November 14, 2018
Applicability and added value of novel methods to improve drug development in rare diseasesMarian Mitroiu, Katrien Oude Rengerink, Caridad Pontes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trialsC Marijn Hazelbag, Sanne A E Peters, Peter J Blankestijn, et al.
Hepatology (Baltimore, Md.)|March 17, 2015
Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter studyFederica Cerini, Javier Martínez Gonzalez, Ferran Torres, et al.
European Journal of Radiology|December 31, 2020
Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practiceJordi Rimola, Leonardo G Da Fonseca, Víctor Sapena, et al.
Pageof 18